{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:00:26Z","timestamp":1789038026922,"version":"build-2803163510"},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":846,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Australasian Journal of Dermatology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1111\/ajd.12054","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T08:48:25Z","timestamp":1368002905000},"page":"75-79","source":"Crossref","is-referenced-by-count":28,"title":["Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis"],"prefix":"10.1111","volume":"55","author":[{"given":"Lucy J","family":"Dang","sequence":"first","affiliation":[{"name":"Dermatology Department; Monash University; Australia"},{"name":"Eastern Health Clinical School; Monash University; Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Lubel","sequence":"additional","affiliation":[{"name":"Box Hill Hospital; Monash University; Australia"},{"name":"Eastern Health Clinical School; Monash University; Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamalar","family":"Gunatheesan","sequence":"additional","affiliation":[{"name":"Dermatology Department; Monash University; Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hosking","sequence":"additional","affiliation":[{"name":"Eastern Health Pathology; University of Melbourne; Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Su","sequence":"additional","affiliation":[{"name":"Dermatology Department; Monash University; Australia"},{"name":"Eastern Health Clinical School; Monash University; Australia"},{"name":"Department of Paediatrics; University of Melbourne; Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,5,8]]},"reference":[{"key":"10.1111\/ajd.12054-BIB0001|ajd12054-cit-0001","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/ajd.12054-BIB0002|ajd12054-cit-0002","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaad.2006.07.017","article-title":"A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis","volume":"56","author":"Menter","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12054-BIB0003|ajd12054-cit-0003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdermsci.2010.04.014","article-title":"Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial","volume":"59","author":"Torii","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1111\/ajd.12054-BIB0004|ajd12054-cit-0004","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/ajd.12054-BIB0005|ajd12054-cit-0005","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta15100","article-title":"Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation","volume":"15","author":"Rodgers","year":"2011","journal-title":"Health Technol. Assess."},{"issue":"2","key":"10.1111\/ajd.12054-BIB0006|ajd12054-cit-0006","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008794.pub2","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview (Review)","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1111\/ajd.12054-BIB0007|ajd12054-cit-0007","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2133.2008.08728.x","article-title":"Review and expert opinion on prevention and treatment of infliximab-related infusion reactions","volume":"159","author":"Lecluse","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1111\/ajd.12054-BIB0008|ajd12054-cit-0008","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.2009.05138.x","article-title":"Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation","volume":"1183","author":"Kong","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1111\/ajd.12054-BIB0009|ajd12054-cit-0009","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/ard.2009.112136","article-title":"Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis","volume":"69","author":"Sokolove","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1111\/ajd.12054-BIB0010|ajd12054-cit-0010","unstructured":"Important drug warning. FDA MedWatch [online] 2004 http:\/\/www.fda.gov\/downloads\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/UCM166923.pdf"},{"key":"10.1111\/ajd.12054-BIB0011|ajd12054-cit-0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11739-009-0342-4","article-title":"Infliximab-related hepatitis: discussion of a case and review of the literature","volume":"5","author":"Mancini","year":"2010","journal-title":"Intern. Emerg. Med."},{"key":"10.1111\/ajd.12054-BIB0012|ajd12054-cit-0012","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2230.2006.02086.x","article-title":"Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis","volume":"31","author":"Wahie","year":"2006","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1111\/ajd.12054-BIB0013|ajd12054-cit-0013","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.22327","article-title":"Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus","volume":"56","author":"Aringer","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1111\/ajd.12054-BIB0014|ajd12054-cit-0014","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2230.2008.03088.x","article-title":"Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriasis","volume":"34","author":"Fairhurst","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1111\/ajd.12054-BIB0015|ajd12054-cit-0015","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.jaad.2009.02.029","article-title":"Autoimmune hepatitis in two psoriasis patients treated with infliximab","volume":"63","author":"Goujon","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1111\/ajd.12054-BIB0016|ajd12054-cit-0016","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0025-6196(11)60668-X","article-title":"Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic","volume":"84","author":"Wetter","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1111\/ajd.12054-BIB0017|ajd12054-cit-0017","doi-asserted-by":"crossref","first-page":"R535","DOI":"10.1186\/ar1440","article-title":"Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study","volume":"6","author":"Ferraro-Peyret","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1111\/ajd.12054-BIB0018|ajd12054-cit-0018","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ibd.20293","article-title":"Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis","volume":"14","author":"Marques","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1111\/ajd.12054-BIB0019|ajd12054-cit-0019","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1468-3083.2007.02310.x","article-title":"Infliximab for patients with plaque psoriasis and severe psychiatric comorbidity","volume":"22","author":"Bassukas","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1111\/ajd.12054-BIB0020|ajd12054-cit-0020","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1365-2133.2011.10555.x","article-title":"Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody","volume":"165","author":"Hoffmann","year":"2011","journal-title":"Br. J. Dermatol."}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajd.12054","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajd.12054\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T10:13:21Z","timestamp":1715336001000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.12054"}},"subtitle":["A clinical review of infliximab use"],"short-title":[],"issued":{"date-parts":[[2013,5,8]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1111\/ajd.12054","relation":{},"ISSN":["0004-8380"],"issn-type":[{"value":"0004-8380","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5,8]]}}}